
Pacific Biosciences of California PACB
$ 2.22
-6.33%
Pacific Biosciences of California EV/EBITDA Ratio | PACB
Annual EV/EBITDA Ratio Pacific Biosciences of California
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.24 | -2.51 | -7.05 | -9.82 | -24.3 | -43.7 | -7.92 | -9.75 | -3.72 | -6.32 | -16.3 | -9.28 | -6.2 | -1.08 | -1.67 | -23.6 | -21.7 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.08 | -43.7 | -11.6 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
DarioHealth Corp.
DRIO
|
-0.303 | $ 2.37 | 15.05 % | $ 9.44 M | ||
|
Myriad Genetics
MYGN
|
-1.79 | $ 5.66 | -1.39 % | $ 524 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.785 | $ 4.78 | -1.24 % | $ 3.76 M | ||
|
QIAGEN N.V.
QGEN
|
-1.27 | $ 50.52 | -0.07 % | $ 11 B | ||
|
NeoGenomics
NEO
|
-23.2 | $ 16.97 | -3.58 % | $ 2.17 B | ||
|
OPKO Health
OPK
|
-51.8 | $ 1.71 | 0.58 % | $ 1.28 B | ||
|
Neogen Corporation
NEOG
|
37.8 | $ 11.67 | -3.44 % | $ 2.54 B | ||
|
Precipio
PRPO
|
988 | $ 23.56 | 6.13 % | $ 37.8 M | ||
|
Personalis
PSNL
|
-4.87 | $ 15.9 | -0.31 % | $ 1.42 B | ||
|
Sotera Health Company
SHC
|
74.5 | $ 16.25 | -1.16 % | $ 4.61 B | ||
|
Quidel Corporation
QDEL
|
9.16 | $ 11.56 | -4.43 % | $ 487 M | ||
|
Centogene N.V.
CNTG
|
0.283 | - | -6.23 % | $ 30.6 M | ||
|
Trinity Biotech plc
TRIB
|
-15.5 | $ 5.88 | 10.08 % | $ 2.11 B | ||
|
Global Cord Blood Corporation
CO
|
-4.15 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.932 | - | 0.12 % | $ 80.1 M | ||
|
Aspira Women's Health
AWH
|
-1.36 | - | -6.19 % | $ 10.5 M | ||
|
Check-Cap Ltd.
CHEK
|
0.000843 | - | - | $ 9.42 M | ||
|
Exact Sciences Corporation
EXAS
|
-270 | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
14.3 | $ 26.91 | 0.9 % | $ 602 M | ||
|
Twist Bioscience Corporation
TWST
|
-13.9 | $ 132.17 | -2.35 % | $ 7.9 B | ||
|
Organovo Holdings
ONVO
|
-0.307 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
0.234 | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
5.25 | - | -0.91 % | $ 14.7 B | ||
|
Soleno Therapeutics
SLNO
|
186 | - | - | $ 2.69 B | ||
|
Enzo Biochem
ENZ
|
2.04 | - | -8.98 % | $ 14.8 K | ||
|
Waters Corporation
WAT
|
60.2 | $ 476.29 | -0.09 % | $ 28.4 B | ||
|
Exagen
XGN
|
-6.55 | $ 5.26 | -25.92 % | $ 113 M | ||
|
Celcuity
CELC
|
-32.4 | $ 67.13 | -4.11 % | $ 3.14 B | ||
|
Laboratory Corporation of America Holdings
LH
|
16 | $ 370.89 | -0.25 % | $ 30.9 B | ||
|
Lantheus Holdings
LNTH
|
15.5 | $ 101.65 | 0.63 % | $ 6.86 B | ||
|
Accelerate Diagnostics
AXDX
|
-2.05 | - | -61.36 % | $ 2.46 M | ||
|
Medpace Holdings
MEDP
|
24.9 | $ 664.97 | -1.18 % | $ 19.2 B | ||
|
Charles River Laboratories International
CRL
|
26.6 | $ 346.21 | -2.02 % | $ 17.2 B | ||
|
Mettler-Toledo International
MTD
|
627 | $ 1 750.2 | -0.69 % | $ 36.1 B | ||
|
Danaher Corporation
DHR
|
26.6 | $ 236.19 | 0.46 % | $ 168 B | ||
|
Koninklijke Philips N.V.
PHG
|
17.1 | $ 30.39 | -1.32 % | $ 28.8 B | ||
|
RadNet
RDNT
|
33.9 | $ 77.91 | -0.6 % | $ 5.86 B | ||
|
Senseonics Holdings
SENS
|
-5.62 | $ 10.05 | 2.55 % | $ 419 M | ||
|
Neuronetics
STIM
|
-6.02 | $ 2.01 | -7.8 % | $ 133 M | ||
|
T2 Biosystems
TTOO
|
-1.13 | - | -39.35 % | $ 313 K | ||
|
Thermo Fisher Scientific
TMO
|
21.2 | $ 719.09 | -0.35 % | $ 271 B | ||
|
Biocept
BIOC
|
-0.496 | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
-38.2 | $ 155.43 | -2.12 % | $ 19.5 B | ||
|
Akumin
AKU
|
23.4 | - | -17.87 % | $ 25.9 M | ||
|
Brainsway Ltd.
BWAY
|
166 | $ 10.63 | -8.68 % | $ 361 M | ||
|
VolitionRx Limited
VNRX
|
-3.21 | $ 0.19 | -6.2 % | $ 23.9 M | ||
|
Natera
NTRA
|
-112 | $ 311.81 | -1.92 % | $ 42.6 B |